Literature DB >> 29563227

Protonation underlies tonic vs. use-dependent block.

Vincenzo Carnevale1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29563227      PMCID： PMC5889681          DOI： 10.1073/pnas.1802178115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  18 in total

Review 1.  Sodium channel mutations in epilepsy and other neurological disorders.

Authors:  Miriam H Meisler; Jennifer A Kearney
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

2.  Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels.

Authors:  D S Ragsdale; J C McPhee; T Scheuer; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

Review 3.  The cardiac ion channels: relevance to management of arrhythmias.

Authors:  D M Roden; A L George
Journal:  Annu Rev Med       Date:  1996       Impact factor: 13.739

4.  Local anesthetic and antiepileptic drug access and binding to a bacterial voltage-gated sodium channel.

Authors:  Céline Boiteux; Igor Vorobyov; Robert J French; Christopher French; Vladimir Yarov-Yarovoy; Toby W Allen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

5.  Prokaryotic NavMs channel as a structural and functional model for eukaryotic sodium channel antagonism.

Authors:  Claire Bagnéris; Paul G DeCaen; Claire E Naylor; David C Pryde; Irene Nobeli; David E Clapham; B A Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-21       Impact factor: 11.205

6.  Protonation state of inhibitors determines interaction sites within voltage-gated sodium channels.

Authors:  Amanda Buyan; Delin Sun; Ben Corry
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-21       Impact factor: 11.205

7.  Molecular determinants of state-dependent block of Na+ channels by local anesthetics.

Authors:  D S Ragsdale; J C McPhee; T Scheuer; W A Catterall
Journal:  Science       Date:  1994-09-16       Impact factor: 47.728

8.  Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist.

Authors:  Shivani Ahuja; Susmith Mukund; Lunbin Deng; Kuldip Khakh; Elaine Chang; Hoangdung Ho; Stephanie Shriver; Clint Young; Sophia Lin; J P Johnson; Ping Wu; Jun Li; Mary Coons; Christine Tam; Bobby Brillantes; Honorio Sampang; Kyle Mortara; Krista K Bowman; Kevin R Clark; Alberto Estevez; Zhiwei Xie; Henry Verschoof; Michael Grimwood; Christoph Dehnhardt; Jean-Christophe Andrez; Thilo Focken; Daniel P Sutherlin; Brian S Safina; Melissa A Starovasnik; Daniel F Ortwine; Yvonne Franke; Charles J Cohen; David H Hackos; Christopher M Koth; Jian Payandeh
Journal:  Science       Date:  2015-12-18       Impact factor: 47.728

Review 9.  Sodium channel mutations and arrhythmias.

Authors:  Yanfei Ruan; Nian Liu; Silvia G Priori
Journal:  Nat Rev Cardiol       Date:  2009-05       Impact factor: 32.419

10.  The crystal structure of a voltage-gated sodium channel.

Authors:  Jian Payandeh; Todd Scheuer; Ning Zheng; William A Catterall
Journal:  Nature       Date:  2011-07-10       Impact factor: 49.962
View more
  3 in total

1.  The citrus flavanone hesperetin preferentially inhibits slow-inactivating currents of a long QT syndrome type 3 syndrome Na+ channel mutation.

Authors:  Julio Alvarez-Collazo; Alejandro López-Requena; Loipa Galán; Ariel Talavera; Julio L Alvarez; Karel Talavera
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

2.  The Citrus Flavonoid Hesperetin Has an Inadequate Anti-Arrhythmic Profile in the ΔKPQ NaV1.5 Mutant of the Long QT Type 3 Syndrome.

Authors:  Julio Alvarez-Collazo; Alejandro López-Requena; Julio L Alvarez; Karel Talavera
Journal:  Biomolecules       Date:  2020-06-24

3.  Structural basis for antiarrhythmic drug interactions with the human cardiac sodium channel.

Authors:  Phuong T Nguyen; Kevin R DeMarco; Igor Vorobyov; Colleen E Clancy; Vladimir Yarov-Yarovoy
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-06       Impact factor: 11.205
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.